Our outcomes indicated that the progression of periodontal disease was more significantly associated with increased levels of RANKL in the control positive group than in the control negative group, possibly leading to marked bone loss and elevation of osteoclast numbers. The gene discussed is TNFSF11; the disease is periodontal disorder.